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Abstract
Objective Mucopolysaccharidosis IVA (MPS IVA, or
Morquio A syndrome) and VI (MPS VI, or Maroteaux–
Lamy syndrome) are autosomal recessive lysosomal storage
disorders. Skeletal abnormalities are common initial present-
ing symptoms and, when recognized early, may facilitate
timely diagnosis and intervention, leading to improved patient
outcomes. Patients with slowly progressing disease and
nonclassic phenotypes can be particularly challenging to di-
agnose. The objective was to describe the radiographic fea-
tures of patients with a delayed diagnosis of MPS IVA or VI.
Materials and Methods This was a retrospective study. The
records of 5 MPS IVA and 3 MPS VI patients with delayed
diagnosis were reviewed. Radiographs were evaluated by a
radiologist with special expertise in skeletal dysplasias.
Results An important common theme in these cases was the
appearance of multiple epiphyseal dysplasia (MED) with
epiphyseal changes seemingly confined to the capital
(proximal) femoral epiphyses. Very few patients had the skel-
etal features of classical dysostosis multiplex.
Conclusions Radiologists should appreciate the wide pheno-
typic variability ofMPS IVA and VI. The cases presented here
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illustrate the importance of consideringMPS in the differential
diagnosis of certain skeletal dysplasias/disorders, including
MED, some forms of spondylo-epiphyseal dysplasia (SED),
and bilateral Perthes-like disease. It is important to combine
radiographic findings with clinical information to facilitate
early testing and accurate diagnosis.
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Introduction
The mucopolysaccharidoses (MPS) are lysosomal storage
disorders caused by defects in glycosaminoglycan (GAG)
catabolism [1] and are classified under the dysostosis multi-
plex group of skeletal dysplasias [2]. The recent emergence of
specific therapies for some of the MPS disorders has brought
to the forefront the importance of accurate and early diagnosis
as a means of improving patient outcomes [3]. However,
limited disease awareness and extensive clinical heterogeneity
contribute to delays in the diagnosis of these rare disorders.
Many radiographic and clinical manifestations of MPS may
mimic those of other skeletal dysplasias, further complicating
the path to diagnosis. Moreover, once clinical suspicion has
been established, limitations and complications associated
with diagnostic assays may delay definitive confirmation [4,
5].
In this paper, we present 8 cases that highlight the chal-
lenges associated with diagnosing MPS IVA (Morquio A
syndrome) and MPS VI (Maroteaux–Lamy syndrome), two
MPS disorders for which enzyme replacement therapy (ERT)
is available or in development [6, 7]. MPS IVA is an autoso-
mal recessive condition resulting from insufficient activity of
N-acetylgalactosamine-6-sulfatase (GALNS), an enzyme that
degrades keratan sulfate and chondroitin-6-sulfate [8]. MPS
VI is an autosomal recessive disorder caused by deficient
activity of N-acetylgalactosamine 4-sulfatase (arylsulfatase B
or ARSB), the enzyme that catabolizes dermatan sulfate [9].
Classic signs and symptoms include short stature, skeletal
abnormalities with some of the characteristic radiographic
changes of dysostosis multiplex, joint problems, respiratory
complications, cardiac disease, ocular abnormalities, and
hearing loss [8–11]. The onset of symptoms usually occurs
within the first 2 years of life in severely affected patients. In
contrast, individuals with more slowly progressive disease
typically develop symptoms later in life and may present with
more subtle disease manifestations, increasing the likelihood
of a delayed or missed diagnosis [12–15]. Many MPS IVA
and VI individuals are at risk of multisystem impairment and
significant morbidity, underscoring the importance of early
diagnosis and multidisciplinary management, regardless of
phenotype [8, 10, 16, 17]. By recognizing the radiographic
abnormalities associated with these disorders, the radiologist
can play a critical role in facilitating timely testing, diagnosis,
and intervention. With the aim of improving radiologists’
recognition of possible MPS disease across a broad spectrum
of presentations and beyond the classic phenotypes, we
reviewed the radiographs and clinical information of 8 pa-
tients who were initially diagnosed with or suspected of
having other skeletal disorders, and discuss the radiographic
findings that might generate suspicion of MPS.
Materials and methods
We reviewed the medical records of 5 MPS IVA and 3 MPS
VI patients with delayed diagnosis. Radiographs were retro-
spectively reviewed by a pediatric radiologist (R.S. Lachman)
with special expertise in skeletal dysplasias. In addition, con-
firmed cases of MPS in the radiographic database of the
International Skeletal Dysplasia Registry were analyzed to
determine the referring and actual diagnoses.
Results
Case 1
Patient 1, a Caucasian female, presented with mid-thoracic
back pain and scoliosis at age 9 years. Her height was
131.2 cm (25th percentile) and her weight was 25.3 kg
(10th percentile). Radiographs were interpreted as revealing
L1 hemivertebra, generalized platyspondyly, and mild epiph-
yseal dysplasia. Cardiac abnormalities (mitral and triscuspid
prolapse), joint laxity, and a barrel-shaped chest were also
noted. Urinary GAG excretion was normal and a diagnosis
of spondylo-epiphyseal dysplasia tarda (SEDT) was made.
Kyphoscoliosis continued to progress. By age 21 years, she
had severe bilateral hip pain; her height at this time was
151 cm (<5th percentile). Between ages 23 and 24 years, both
hips were replaced. Corneal dystrophy (pre-Descemet’s dys-
trophy) was noted at age 25. Vocal cord nodules were re-
moved at age 27. The patient returned to genetics at age 29
to discuss the potential risks to future offspring. A repeat
urinary GAG screen did not reveal abnormalities. However,
a review and discussion of this case with a metabolic specialist
prompted enzymatic activity testing for and subsequent diag-
nosis of MPS IVA.
Figure 1 shows radiographs of this patient obtained in late
adolescence. Review of these radiographs reveals a hypoplas-
tic L1 vertebral body (no apparent hemivertebra formation)
resulting in a mild gibbus and scoliosis. There is no evidence
of platyspondyly. The ribs are normal in size and contour, but
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down-tilted resulting in a narrow thorax. There are dysplastic
capital femoral epiphyses (CFE) with normally formed iliac
wings. Knee epiphyses and all other epiphyses are normal.
Hand/wrist films are normal. None of these findings is char-
acteristic of dysostosis multiplex to suggest MPS disease;
however, a form of multiple epiphyseal dysplasia (MED) is
suggested by this radiographic survey.
The final diagnosis was MPS IVA.
Case 2
Patient 2, a Caucasian girl, was noted to have an abnormal gait
during a routine pediatric examination at age 4. Her height and
weight at age 5 years were 109 cm (9th percentile) and 20 kg
(52nd percentile) respectively. At age 6, the patient was ad-
mitted to a pediatric hospital for diagnostic evaluation due to
gait abnormalities, weakness, and motor developmental delay.
An MRI of the hips was interpreted as normal and excluded
Legg–Calvé–Perthes disease (Perthes disease). Clinical eval-
uations including echocardiography were normal. At age
7 years she was seen by an orthopedic surgeon. Radiographs
and an MRI of the spine showed “protrusion of L2,” while re-
evaluation of the hip MRI and a hip radiograph revealed
bilateral flattening of the epiphyses of the femoral heads.
She was diagnosed with MED. A second orthopedic surgeon
suspected SED because of some involvement of the spine and
a genetics evaluation was recommended. Suspicion of MPS
IVA prompted diagnostic testing for lysosomal storage disor-
ders. Urinary GAG excretion was normal, but reduced
GALNS activity led to a diagnosis of MPS IVA at age 8.
Her height at diagnosis was 119.5 cm (3rd percentile).
Radiographic review of the plain films at ages 6–8 years
(Fig. 2) reveals normal iliac wings and dense dysplastic CFE.
The remaining epiphyseal centers, including the knees, are all
normal. The hand and wrist film suggests mild generalized
brachydactyly, mildly widened phalangeal growth plates, and
poor formation of the proximal metacarpals, somewhat like
proximal pointing (these changes are subtle). The carpal bones
are small and dysplastic with ossification delay. The lateral
spine at age 6 years reveals several vertebrae with residual
mild middle beaking (T11 and T12) and one superior notched
vertebra (L1). The hand and spine findings suggest dysostosis
multiplex. The bilateral dysplastic CFE, mild brachydactyly,
and dysplastic carpal centers suggest the possibility of some
form of MED.
The final diagnosis was MPS IVA.
Case 3
Patient 3, a Korean male, first presented with hip pain at age
11 years, and bilateral Perthes-like disease was suspected.
Aggravated hip pain led him to see an orthopedic surgeon at
age 27 years. He is of average stature for an adult Korean
male, with a height of 169 cm and a weight of 74 kg.
Radiographic abnormalities of the spine, pelvis/hips, and
knees led to suspected X-linked SEDT, but this was not
confirmed by mutation analysis of SEDL (TRAPPC2).
Molecular testing for SEDC (COL2A1) and MED (COMP,
MATN3, COL9A1-3) did not reveal any deleterious mutations
either. Whole exome sequencing identified two GALNS mu-
tations, c.317A>G (p.N106S) and c.553delG (p.E185Rfx14),
which were confirmed by Sanger sequencing. These muta-
tions have not been previously reported among individuals
with MPS IVA or any other disease. The patient is a com-
pound heterozygote for these two mutations. Reduced
GALNS activity confirmed a diagnosis of MPS IVA.
Radiographic review of this patient (Fig. 3) at age 27 shows
kyphoscoliosis and mild platyspondyly with several superior/
inferior humped vertebral bodies (L1–L3). The pelvis/hip film
reveals normal iliac wings and dysplastic femoral heads with
joint space narrowing and acetabular sclerosis (secondary
degenerative arthrosis). The hand and wrist films appear nor-
mal. The films of the hips and spine do indeed suggest the
diagnosis of SEDT. There are no findings radiographically
that suggest any form of MPS. The radiographs also suggest
MED as a possible diagnosis.
The final diagnosis was MPS IVA.
Case 4
Patient 4, a 2 ½ -year-old Caucasian girl with “congenital
kyphosis”, was seen by orthopedics because of parental con-
cerns about prominent hardware, a waddling gait, and reduced
mobility. A genetics evaluation at age 3½years revealed a
height of 96.5 cm (29th percentile). Proximal femoral epiph-
yseal flattening was detected on radiographs and a type II
collagenopathy was considered; however, the mutation anal-
ysis was not consistent with a type II collagenopathy. At age 9,
her height was 116.5 cm (< 3rd percentile). Mitral valve
thickening, mild tricuspid insufficiency, and restrictive lung
disease were observed. Slightly elevated urinary GAG levels
prompted enzyme activity analysis. She was diagnosed with
MPS IVA based on reduced GALNS activity. She is a com-
pound heterozygote for two known GALNS missense muta-
tions, c.776G>A (p.R259Q) and c.901G>T (p.G301C) [18].1
Review of the radiographs of this patient (Fig. 4) shows
mild but significant changes of dysostosis multiplex with
dysplastic CFE. Spine films at age 2½years reveal a gibbus
and scoliosis. There is a hypoplastic T12 and a middle beaked
L1. On the pelvis/hip film at age 9 years, mild inferior tapering
of the iliac wings is observed. Bilateral dysplastic CFE are
again seen (confirmed earlier by MRI and hip arthrography),
with otherwise normal epiphyseal centers elsewhere. The
hands are normal aside from nonspecific carpal ossification
1 Previously published in Mendelsohn et al. [18]
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Fig. 1 Radiographs of patient 1,
female, Morquio A syndrome
(MPS IVA). aAntero-posterior
(AP) pelvis and hips, age
17 years: hypoplastic dense
capital femoral epiphyses (CFE).
bAP chest, age 17 years: normal.
c Lateral spine, age 17 years:
hypoplastic L1 vertebral body
producing a significant gibbus.
dAP hand and wrist, age
17 years: normal
Fig. 2 Radiographs of patient 2,
female, MPS IVA. aAP pelvis
and hips, age 7 years: normal
pelvis; bilateral dense/dysplastic
CFE. b Lateral lumbar spine, age
6 years: slightly abnormal with
mild residua of the middle
beaking of several vertebrae
(T11, T12) and a slightly superior
notched L1. cAP right hand and
wrist, age 8 years: mild
generalized brachydactyly; wide
growth plates and hypoplastic
carpal centers; no significant




delay. Overall, there are significant findings of dysostosis
multiplex including dysplastic changes of the CFE similar to
those observed in the other cases.
The final diagnosis was MPS IVA.
Case 5
Patient 5 is a physically active Caucasian boy who started
limping at age 4 years and started experiencing knee pain at
age 5 years. He was diagnosed with bilateral Perthes disease at
age 7. He presented to the skeletal dysplasia clinic at age
9 years, when his height was 125.2 cm (5.5th percentile) and
his weight was 27.1 kg (30th percentile). Mild scoliosis was
the only abnormality noted on physical examination. Two
urinary GAG screens were normal. SEDC, Stickler syndrome,
and X-linked SEDT were considered, but not confirmed by
molecular testing. After 1 year, he returned to the clinic with a
developing chest wall deformity and increasing hip pain.
Reduced GALNS activity led to a diagnosis of MPS IVA.
One copy of the c.901G>T (p.G301C) mutation on the
GALNS gene was identified [18].2
Retrospective evaluation of the radiographs of this patient
(Fig. 5) reveals no specific evidence of dysostosis multiplex.
The pelvic films reveal normal ilia, with rather poor acetabular
roof formation. There are dysplastic CFEs; all other epiphyses
appear quite normal. The spine radiographs show several
mildly hypoplastic vertebral bodies (T11 and T12) and poste-
rior scalloping in the thoracolumbar junctional region. Some
form of either MED or SED are suggested by these films.
The final diagnosis was MPS IVA.
Case 6
Patient 6, a Caucasian girl, was referred to orthopedics at age
6 years because of mildly short stature, an abnormal gait, and
toe-walking. Her height at the time was 110 cm
(10th percentile). At age 7, a diagnosis of spondylo-
epiphyseal dysplasia congenita (SEDC) was established based
on apparent radiographic abnormalities of the pelvis and
spine. Snoring and a history of frequent ear infections
prompted referral to an ear/nose/throat (ENT) specialist, and
she underwent tonsillectomy and adenoidectomy at age 7. She
was diagnosed with hearing loss and chronic otitis media at
age 9. During recurrence risk counseling for SEDC, a genet-
icist clinically suspected MPS based on a photograph of the
patient (coarse facial features). Enzyme activity testing at age
10 established a diagnosis of MPS VI.
Radiographs of this patient taken at age 8 were reviewed
(Fig. 6). The characteristic changes of dysostosis multiplex are
not evident in this patient. The asymmetrical and mildly2 Previously published in Mendelsohn et al. [18]
Fig. 3 Radiographs of patient 3,
male, MPS IVA. aAP pelvis and
hips, age 27 years: mildly
dysplastic CFE with joint space
narrowing; sclerosis
(degenerative arthrosis). bAP
spine and lower ribs, age 27 years:
scoliosis; normal paddle-shaped
ribs (T9–T12). c Lateral spine,
age 27 years: several superior
humped vertebral bodies in the
lumbar spine. dAP hands and
wrists, age 27 years: normal
Skeletal Radiol
dysplastic changes of the CFE appear to mimic MED. The
lateral thoracic and lumbar spine film shows a single mildly
superior notched vertebra (T9) in the lower thoracic spine (a
subtle finding), which is not diagnostic of dysostosis multi-
plex and can be seen with hypotonia, etc. The mild scoliosis
alone does not constitute sufficient spinal involvement for any
well-described type of SED.
The final diagnosis was MPS VI.
Case 7
Patient 7 is a girl of Asian origin who was seen by orthopedics
at 9 years of age because of short stature. Her radiographs
were interpreted as showing bilateral acetabular dysplasia
with coxa magna, deformities of the femoral heads, and
epiphyseal and metaphyseal abnormalities. Corneal clouding
was noted, therefore the possibility of MPS was raised and the
patient was referred to genetics. Physical examination re-
vealed a height of 117.5 cm (<5th percentile), weight of
22.0 kg (5th percentile), and head circumference of 54.5 cm
(+1 SD). Some limitation of range of motion of the shoulder
was noted. A second review of her radiographs led to an initial
impression of MED and referral to a skeletal dysplasia clinic.
Bilateral corneal opacities were observed upon ophthalmolog-
ical examination. At age 10 years, a heart murmur was detect-
ed. Subsequent cardiology assessments revealed mitral valve
Fig. 4 Radiographs of patient 4,
female, MPS IVA. aAP pelvis
and hips, age 9 years: dysplastic
CFE; mildly tapered lower iliac
wings merging into the acetabular
roofs. bAP spine and ribs, age
9 years: severe scoliosis with
hardware; normal ribs. c Lateral
spine, age 2½years: gibbus;
hypoplastic T12; middle beaked
L1. dAP hands and wrists, age 6
years: relatively normal,
but carpal ossification delay
Fig. 5 Radiographs of patient 5,
male, MPS IVA. aAP pelvis and
hips, age 7 years: dysplastic
superiorly eroded CFE. b Lateral
spine, age 9 years: kyphosis;
mildly hypoplastic T11 and T12
and posterior scalloping
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thickening, mitral valve prolapse, mild mitral regurgitation,
and mild aortic insufficiency. At a follow-up genetics
visit, mild valgus deformity of the knees, a waddling
gait, lordosis of the spine, and a broad flat nasal bridge were
noted. Review of the patient’s history and symptoms led to
suspicion of anMPS disorder and prompted diagnostic testing
for lysosomal storage disorders and a full skeletal survey.
MPS VI was diagnosed based on low ARSB activity in
leukocytes.
Figure 7 shows the chest and pelvis/hip radiographs of
this patient obtained at age 11 years (most recent modified
skeletal survey). A review of these radiographs reveals
thick ribs and clavicles, which are characteristic of
dysostosis multiplex. The pelvis film shows mild residua
of lower ileal tapering. The CFE changes are MED-like.
Overall, there are some mild suggested features of dysostosis
multiplex.
The final diagnosis was MPS VI.
Case 8
Patient 8, a Caucasian boy, was diagnosed with bilateral
Perthes-like disease, but was referred to genetics at age
10 years for possible skeletal dysplasia. On physical
examination his height was 143 cm (65th percentile), his
weight was 43.5 kg (92th percentile), and head circumfer-
ence was 56.2 cm (95th percentile). He was noted to have
mild scoliosis, a protuberant abdomen, thickened gums, and
hyperreflexia at his knees and ankles. Radiographs were
interpreted to reveal symmetrical epiphyseal abnormalities
of the proximal femurs and irregularities of one vertebral
endplate. His urinary GAG screen was normal; however, a
trace amount of dermatan sulfate was observed. Molecular
testing of the COL2A1 gene and the COL11A2 gene did not
reveal any deleterious mutations that would diagnose
SEDC and Stickler dysplasia respectively. At age 12 years,
the patient returned to clinic with continuing hip pain.
Repeat screening for MPS revealed mildly elevated urinary
GAG excretion as well as trace levels of dermatan sulfate,
prompting enzyme activity analysis for MPS VI. Low
ARSB activity and subsequent molecular testing confirmed
a diagnosis of MPS VI. This patient is homozygous for the
c.629A>G (p.Y210C) missense mutation in the ARSB gene
[18].3
On review, radiographs of this patient (Fig. 8) reveal hy-
poplastic CFE and a single superiorly notched T12 vertebral
3 Previously published in Mendelsohn et al. [18]
Fig. 6 Radiographs of patient 6,
female, Maroteaux-Lamy
syndrome (MPS VI). aAP pelvis
and hips, age 8 years: relatively
normal pelvis; CFE are a little
dysplastic with asymmetrical
involvement; superior flattening,
but erosive notching on the right.
bAP spine and ribs, age 8 years:
mild scoliosis (nonspecific
finding); spine otherwise normal;
ribs are normal without
thickening/paddle shaping;
clavicles are normal. c Lateral
spine, age 8 years: mildly
superiorly notched T9
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body (nonspecific finding). No other skeletal abnormalities
suggesting dysostosis multiplex are recognized.
The final diagnosis was MPS VI.
Summary
Taken together, all of these cases demonstrate that MPS dis-
ease may often be radiographically confused with other skel-
etal dysplasias/entities, in particular MED, SED, and bilateral
Perthes-like disease.
International Skeletal Dysplasia Registry database search
A search in the International Skeletal Dysplasia Registry re-
veals that of the total 151 cases of confirmed dysostosis mul-
tiplex submitted for evaluation, approximately 75 % of refer-
ring physicians did not recognize the likelihood that their case
clinically/radiologically represented a form of MPS disease.
MED, SEDC, Dyggve–Melchior–Clausen dysplasia including
Smith–McCort syndrome, and pseudo-achondroplasia were
among the most common referring diagnoses.
Discussion
Diagnosing MPS IVA or VI can be a challenging and
protracted process, as illustrated by the cases described here.
An accurate diagnosis typically requires recognition of spe-
cific clinical and/or radiographic signs and symptoms com-
bined with laboratory confirmation, which often involves
multidisciplinary input. Delayed or incorrect diagnosis can
result from a number of factors including the incorrect inter-
pretation of radiographs, lack of disease awareness, wide
phenotypic variability, phenotypic overlap with other disor-
ders, and limitations of urinary GAG screening. The radiolo-
gist can play a critical role in ensuring that an accurate diag-
nosis is reached expeditiously by raising suspicion of an MPS
disorder if dysostosis multiplex changes are evident.
However, our retrospective study reveals a significant finding:
MPS disease can radiographically manifest as an apparent
type of MED with isolated dysplastic CFE (MED Ribbing
type) with very few, if any, additional findings suggestive of
classical dysostosis multiplex. MED Ribbing type is charac-
terized by epiphyseal ossification delay and dysplastic-
Fig. 7 Radiographs of patient 7,
female, MPS VI. aAP pelvis and
hips, age 11 years: slightly
abnormal pelvis with mild residua
of inferior ileal tapering; bilateral
CFE dysplasia with flattened
epiphysis on the right and flat
erosive changes on the left. bAP
chest, age 11 years: the ribs are
thick, but not paddle-shaped;
clavicles are also thick. cAP hand
and wrist, age 11 years: normal;




appearing epiphyses, usually by definition confined to the
hips [19].
As our case series illustrates, musculoskeletal abnormali-
ties, including growth delay, abnormal gait and hip pain, are
among the first clinical symptoms to appear and typically
prompt a patient or the family to seek medical attention.
Dysostosis multiplex, associated with the findings summa-
rized in Table 1, is highly suggestive of the diagnosis of
MPS [11]. Only a few patients in our series presented with
findings of dysostosis multiplex, and many of these features
were subtle. The dysplastic MED-like changes of the CFE
observed in our patients, although seen at times in MPS, have
not previously been described as a diagnostic feature of any
form of MPS disease. This finding may be useful in identify-
ing possible nonclassic MPS phenotypes. Our retrospective
study also suggests that MPS IVA and VI might be frequently
misdiagnosed as SED based on incorrect radiographic
interpretation; therefore, it is important to note that a diagnosis
of SED based solely on scoliosis, kyphosis, and/or a single
superior notched vertebra without the presence of either
platyspondyly or superior/inferior humping of vertebral bod-
ies is not consistent with any known form of SED. This case
series suggests that MPS should be considered in the differ-
ential diagnosis of MED, some forms of SED, and bilateral
Perthes-like disease, including Meyer’s dysplasia [20].
Conducting a full skeletal survey is mandatory if an MPS
or other skeletal dysplasia is suspected; imaging only one or a
few regions is likely to result in missed findings and may lead
to a delayed or incorrect diagnosis. It is also important to note
that some changes of dysostosis multiplex, such as proximal
pointing of the metacarpals, vertebral body changes, and
lower ileal changes, may become impossible to detect after
the time of epiphyseal plate fusion. For patients who may not
present with apparent clinical symptoms until late childhood
Fig. 8 Radiographs and MR
image of patient 8, male, MPSVI.
aAP pelvis and hips, age
12 years: hypoplastic CFE. bAP
chest, age 12 years: normal. c
Lateral spine, age 12 years:
superior notched T12 vertebral
body. dMRI lateral spine, age
12 years: anterior/superior
vertebral body irregularity/
notching with intact region of
cartilaginous anlage. eAP hands
and wrists, age 10 years: normal
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or adulthood, review of early or pre-pubertal radiographs can
be quite helpful if they are available.
If an MPS disorder or other skeletal dysplasia is suspected,
a comprehensive examination that includes clinical findings
must be conducted, which requires collaboration between the
radiologist, referring clinician, and the clinical geneticist.
Extra-skeletal manifestations, including corneal clouding,
specific cardiac abnormalities, and facial dysmorphology,
can provide vital clues for achieving a correct diagnosis of
MPS, but are often overlooked or missed due to a lack of
disease awareness, as demonstrated by several of our cases.
Diagnostic enzyme testing is required for the definitive
diagnosis of MPS IVA or VI [4, 5]. Urinary GAG analysis
alone is unreliable and can be misleading, as illustrated by
several of the cases. Molecular analysis can be useful in
diagnosing or confirming a diagnosis of an MPS disorder.
Unless two known pathogenic gene mutations have been
identified on separate alleles, enzyme activity testing should
always be used to confirm a diagnosis of MPS IVA or VI. If
molecular testing is not performed to confirm enzyme activity
results, it is important to measure the activity of a second
sulfatase enzyme to exclude multiple sulfatase deficiency [4,
5]; additionally, for suspected MPS IVA, it is highly recom-
mended to also measure β-galactosidase activity to rule out
MPS IVB [4]. Accurate diagnosis requires corroboration of
complete radiographic and clinical information with the labo-
ratory findings. Once diagnosed, MPS IVA and VI patients
should receive multidisciplinary care and can be considered
for ERT or other therapeutic intervention if such treatment
modalities are available.
Conclusions
While recognition of dysostosis multiplex changes can facil-
itate the timely diagnosis of MPS disease, our study indicates
that MPS IVA and VI can manifest radiographically as MED
with isolated dysplastic CFE (MED Ribbing type), with very
few, if any, additional findings to suggest dysostosis multi-
plex. The cases presented here illustrate the wide phenotypic
variability of these disorders, underscore the importance of
considering MPS in the differential diagnosis of certain skel-
etal dysplasias/disorders, particularly MED, SED, and bilater-
al Perthes-like disease, and emphasize the need to combine
radiographic, clinical, biochemical and molecular findings to
achieve an accurate diagnosis.
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Skeletal region Dysostosis multiplex manifestations
Skull Abnormal J-shaped sella turcica
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Thorax Short, thick clavicles
Paddle-/oar-shaped ribs
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Proximal humeral notching
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Hypoplastic distal ulnae
Thick short diaphyses
Hands Proximally pointed metacarpals
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Feet Tarsal bones with irregular contours
Entities in italics are classical diagnostic findings of dysostosis multiplex
MPS IVA mucopolysaccharidosis IVA (or Morquio A syndrome), CFE
capital femoral epiphysis
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